Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
基本信息
- 批准号:10594366
- 负责人:
- 金额:$ 24.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-22 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAdultAffectAllelesAmino AcidsAtrophicBiochemicalBiologyBloodBone marrow failureCRISPR/Cas technologyCell DeathCell LineCell NucleolusCell physiologyCellsChildhoodChromosomesClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplexCytoplasmDNA RepairDefectDiseaseDissectionEmbryoEukaryotic CellExocrine pancreatic insufficiencyExperimental DesignsFertilizationFishesFunctional disorderG6PC3 geneGenerationsGenesGeneticGoalsGrowthHealthHematopoiesisHumanHuman Cell LineInvestigationKnock-outKnowledgeLeadMaintenanceMetabolicMetabolic PathwayMetabolic stressMetabolismMethodsModelingMolecularMusMutateMutationMyelogenousNeoplasmsNeutropeniaNutrientOrthologous GenePancreasPathogenesisPathway interactionsPatientsPhenocopyPhenotypePolyribosomesProcessProductionProtein BiosynthesisProteinsQuality of lifeRNARecommendationRibosomesRiskShwachman-Diamond syndromeSomatic MutationStressSurvival RateSyndromeTP53 geneTextTissuesTranslatingValidationWestern BlottingZebrafishautosomebiological adaptation to stressbone marrow failure syndromecancer predispositioncell behaviorchromosome 20q lossgenetic analysishuman diseaseimprovedinnovationlipid metabolismmodel organismmutantneutrophilnovelnovel therapeuticspressureprotein metabolismprototyperecruitresponseribosomopathyskeletal dysplasia
项目摘要
(PLEASE KEEP IN WORD, DO NOT PDF)
Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text.
A metabolically active cell contains as many as 107 ribosomes, which are composed of RNA and protein. These complex biochemical machines synthesize proteins at a rate of 200 amino acids per minute with extremely high efficiency and fidelity. Germline or somatic defects in genes encoding components or regulators for ribosome assembly or function cause ribosomopathies, which occur in pediatric and adult patients. Shwachman-Diamond syndrome (SDS) is a prototypic ribosomopathy. SDS is characterized by exocrine pancreatic insufficiency, neutropenia, skeletal dysplasia, and short stature. Genetic ablation of Sbds results in early embryonic lethality (ED 6.5) in mice. The zebrafish Sbds protein is ~90% identical to the human ortholog. We created sbds, efl1, and eif6 zebrafish knockout strains that phenocopy SDS. Based on biochemical and genetic analysis of human and fish tissues, we hypothesize that the loss of SBDS produces disease due to EIF6 accumulation and subsequent aberrant metabolism. When these biochemical responses are excessive, metabolic defects, growth arrest, cell death, and tissue atrophy ensue. Initially adaptive, TP53 mutations may become maladaptive. Using available zebrafish, cell lines, and patient-derived tissues and established methods, we propose the following specific aim to address our hypothesis: Identify the cellular compartment for EIF6 accumulation and characterize its effects on metabolic pathways that could contribute to the pathogenesis of SDS. Our long-term goals are to gain greater knowledge on how ribosomopathies cause human disease and translate new biomedical knowledge to improve the quality of life for those afflicted, particularly SDS.
(请保持言语,不要PDF)
在此处输入文本,这是您应用程序的新摘要信息。本节必须不超过30行文本。
代谢活性细胞包含多达107个核糖体,由RNA和蛋白质组成。这些复杂的生化机器以每分钟200个氨基酸的速度合成蛋白质,效率极高和保真度。编码核糖体组件或功能调节剂的基因中的生殖线或体细胞缺陷会导致核糖体病,这发生在小儿和成年患者中。 Shwachman-Diamond综合征(SDS)是一种原型核糖瘤病。 SDS的特征是外分泌胰腺功能不全,中性粒细胞减少症,骨骼发育不良和身材矮小。 SBD的遗传消融导致小鼠早期胚胎致死性(ED 6.5)。斑马鱼SBD蛋白与人类直系同源物相同。我们创建了SBD,EFL1和EIF6斑马鱼敲除菌株,这些敲除SDS。基于人类和鱼类组织的生化和遗传分析,我们假设SBD的丧失由于EIF6的积累和随后的异常代谢而产生疾病。当这些生化反应过多时,随之而来的是代谢缺陷,生长停滞,细胞死亡和组织萎缩。最初自适应,TP53突变可能成为适应不良的。使用可用的斑马鱼,细胞系和患者衍生的组织以及已建立的方法,我们提出了以下特定目的来解决我们的假设:确定EIF6积累的细胞区室,并表征其对代谢途径的影响,这可能有助于SDS的发病机理。我们的长期目标是获得有关核糖病如何引起人类疾病并翻译新的生物医学知识以改善患者(尤其是SDS)的生活质量的知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seth Joel Corey其他文献
Seth Joel Corey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seth Joel Corey', 18)}}的其他基金
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
8927960 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
9323833 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Multiscale Modeling of Myelodysplastic Syndromes
骨髓增生异常综合征的多尺度建模
- 批准号:
9144830 - 财政年份:2015
- 资助金额:
$ 24.15万 - 项目类别:
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
继发性 MDS/AML 中癌症干细胞的基因修饰
- 批准号:
8644088 - 财政年份:2014
- 资助金额:
$ 24.15万 - 项目类别:
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
继发性 MDS/AML 中癌症干细胞的基因修饰
- 批准号:
8787717 - 财政年份:2014
- 资助金额:
$ 24.15万 - 项目类别:
The F-BAR protein CIP4 in WAS-dependent thrombocytopenia
WAS依赖性血小板减少症中的F-BAR蛋白CIP4
- 批准号:
8322103 - 财政年份:2011
- 资助金额:
$ 24.15万 - 项目类别:
The F-BAR protein CIP4 in WAS-dependent thrombocytopenia
WAS依赖性血小板减少症中的F-BAR蛋白CIP4
- 批准号:
8202444 - 财政年份:2011
- 资助金额:
$ 24.15万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7680896 - 财政年份:2006
- 资助金额:
$ 24.15万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7190561 - 财政年份:2006
- 资助金额:
$ 24.15万 - 项目类别:
Targeted Therapy of Lyn in Myelodysplastic Syndrome
Lyn 治疗骨髓增生异常综合征的靶向治疗
- 批准号:
7034786 - 财政年份:2006
- 资助金额:
$ 24.15万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the coordinated endothelial-epithelial interactions in adult hair cycle of mouse skin
研究小鼠皮肤成年毛发周期中协调的内皮-上皮相互作用
- 批准号:
10674132 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
The Role of Bone Sialoprotein in Modulating Periodontal Development and Repair
骨唾液酸蛋白在调节牙周发育和修复中的作用
- 批准号:
10752141 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 24.15万 - 项目类别: